Vontobel Holding Ltd. Biocryst Pharmaceuticals Inc Transaction History

Vontobel Holding Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$14.21 - $17.65 $99,470 - $123,549	-7,000 Reduced 13.78%	43,800 $629,000
Q2 2021 Aug 06, 2021	BUY	$9.5 - $17.24 $142,500 - $258,599	15,000 Added 41.9%	50,800 $803,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $120,646 - $308,238	35,800 New	35,800 $267,000

280

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.39B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.